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Background: In-vivo quantification of cardiac perfusion is of great research and clinical value. The dual-bolus strategy
is universally used in clinical protocols but has known limitations. The dual-saturation acquisition strategy has been
proposed as a more accurate alternative, but has not been validated across the wide range of perfusion rates
encountered clinically. Dual-saturation acquisition also lacks a clinically-applicable procedure for optimizing parameter
selection. Here we present a comprehensive validation study of dual-saturation strategy in vitro and in vivo.
Methods: The impact of saturation time and profile ordering in acquisitions was systematically analyzed in a phantom
consisting of 15 tubes containing different concentrations of contrast agent. In-vivo experiments in healthy pigs were
conducted to evaluate the effect of R2* on the definition of the arterial input function (AIF) and to evaluate the
relationship between R2* and R1 variations during first-pass of the contrast agent. Quantification by dual-saturation
perfusion was compared with the reference-standard dual-bolus strategy in 11 pigs with different grades of myocardial
perfusion.
Results: Adequate flow estimation by the dual-saturation strategy is achieved with myocardial tissue saturation times
around 100 ms (always <30 ms of AIF), with the lowest echo time, and following a signal model for contrast conversion
that takes into account the residual R2* effect and profile ordering. There was a good correlation and agreement
between myocardial perfusion quantitation by dual-saturation and dual-bolus techniques (R2 = 0.92, mean difference of
0.1 ml/min/g; myocardial perfusion ranges between 0.18 and 3.93 ml/min/g).
Conclusions: The dual-saturation acquisition strategy produces accurate estimates of absolute myocardial perfusion
in vivo. The procedure presented here can be applied with minimal interference in standard clinical procedures.
Keywords: Dual saturation acquisition strategy, Absolute quantitative cardiac perfusion, Cardiovascular magnetic
resonanceBackground
Myocardial perfusion is affected by several pathological sit-
uations, and the degree of myocardial hypo-perfusion cor-
relates with clinical prognosis [1-3]. There is a need for safe
noninvasive techniques that accurately quantify absolute
myocardial perfusion. Cardiovascular magnetic resonance
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article, unless otherwise stated.imaging tool for absolute quantification of myocardial per-
fusion, and its performance compares well with positron
emission tomography (PET) [4].
Semi-quantitative methods based on the contrast
enhancement ratio [5,6] or upslope index [7,8] have
been proposed as a means of obtaining quantitative
results from first-pass MR images; however, these ap-
proaches systematically underestimate myocardial per-
fusion reserve (MPR) compared with fully quantitative
methods [9]. Fully quantitative measurement of absolute
myocardial perfusion has been achieved with a dual-
bolus protocol [10], in which a dilute bolus of contrast-ed Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
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Sánchez-González et al. Journal of Cardiovascular Magnetic Resonance  (2015) 17:21 Page 2 of 12agent is injected at the beginning of the acquisition,
followed by a full-concentration bolus of the same
volume [11]. The dilute bolus ensures a sub-
saturating concentration of contrast agent in the left
ventricle during measurement of contrast enhance-
ment in the blood pool (arterial input function, AIF).
The second bolus, of undiluted contrast agent, allows
accurate estimation of contrast uptake by the
myocardium. This method has been validated against
microspheres in an animal model, showing a good
correlation across low, normal, and hyperemic myo-
cardial blood flow (MBF) [10], and a patient study
showed good agreement with MPR estimates by PET
[4]. However, clinical implementation of the dual-
bolus method is not trivial because of the many ma-
nipulations required [11,12], limiting its inclusion in
clinical routine. Moreover, the delay between bolus
injections means that it is not possible to ensure ac-
quisition of AIF and muscle information in the same
cardiac situation.
An alternative approach is dual-saturation acquisi-
tion, in which AIF and myocardial tissue information
are collected after injection of a single bolus of
undiluted contrast agent [13]. In this approach, signal
saturation during AIF definition is avoided by using
a short saturation time, and myocardial tissue infor-
mation is subsequently obtained with longer satur-
ation times [13,14]. MBF estimation by this method
requires careful control of three parameters: satur-
ation times for accurate evaluation of contrastPhantom analysis. 
Identification of ideal 






Figure 1 Validation process. Systematic validation followed in this workenhancement in the blood pool and cardiac muscle;
R2* effects, especially during AIF estimation [15]; and
the influence of k-space ordering during high reso-
lution image read-out [16].
The purpose of this study was to define a clinically
useful procedure for accurate quantification of myo-
cardial perfusion using the dual-saturation strategy.
Using state-of-the-art 3Tesla-CMR, we analyzed the
influence of saturation time (TS), echo time (TE),
contrast injection rate, and image profile ordering on
estimates of AIF and myocardial contrast uptake in a
set of in-vitro (phantom) and in-vivo (large animal
model) experiments (Figure 1). Signal acquisition and
modeling derived from the in vitro analysis were in-
corporated in an in vivo comparison of the dual-bolus
and dual-saturation strategies over a wide range of
perfusion values, including hypo-perfusion (post-infarct),
normal, and hyperemic MBF (pharmacological hyperemia),
revealing generation of accurate MBF maps by dual-
saturation CMR.
Methods
All imaging experiments were performed on a 3T-TX
Achieva platform (Philips Healthcare, The Netherlands)
equipped with a 32-channel phased-array cardiac coil.
Phantom experiments
The phantom consisted of 15 plastic 50 ml falcon tubes,
each filled with distilled water and a specific concentration




In vivo validation 
across a range of 
perfusion values 
(hypo, normo and 
hyperperfusion states)
to assess accurate cardiac flow estimation by dual saturation technique.
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ranging from 0 to 22.5 mM. Three imaging experiments
were performed with the same phantom to evaluate the ef-
fect of contrast concentration on R1 values and saturation
times, and the influence of profile ordering on estimated
final contrast concentration.
Estimation of R1 values at different contrast concentrations
Gold-standard T1 values of each tube were estimated
using a look-locker inversion recovery acquisition with
147 inversion times ranging from 6.06-5886.06 ms, with
a time interval of 40 ms. A new inversion pulse was ap-
plied every 10 s to avoid signal saturation. To reduce the
influence of excitation readout at different inversion
times, an excitation flip angle of 5° was applied during
the TFE shot [17]. For tubes with R1 higher 20Hz, a sec-
ond sequence was applied with lower TR and FA (TR/
FA = 3 ms/2°). In both cases the final R1 values were es-
timated by fitting the signal intensity at different inver-
sion times to the previously described signal model [17].
Evaluation of saturation times at different contrast
concentrations
The second experiment was designed to evaluate the sig-
nal behavior at different saturation times and contrast
concentrations. All parameters except TS were held con-
stant (single shot TFE, TR/TE/FA = 2.26 ms/1.07 ms/15°),
and ten images of each tube were acquired at TS = 10, 20,
30, 40, 50, 60, 70, 80, 90 and 200 ms. An additional proton
density (SPD) image was acquired without saturation pulse
to normalize the signal intensity of each contrast concen-
tration (S/SPD). All images were acquired by low-high pro-
file ordering to enable short TS and to avoid read-out
effects on signal intensity.
Evaluation of the influence of profile ordering on estimated
final contrast concentration
The third phantom experiment was designed to evaluate
the influence of profile ordering on the conversion of
MR signal changes into contrast concentration varia-
tions. This experiment was performed with 13 of the
tubes with fixed TS of 100 ms. The read-out sequence
was based on single-shot spoiled TFE acquisition (TR/
TE/FA/TFEshot = 1.95 ms/0.9 ms/15°/55shots) with half-
scan factors of 65% and linear and reverse-linear profile
ordering. For each tube, we also computed signal inten-
sity with the signal model described in the Appendix,
using different T1 values and the same acquisition pa-
rameters in order to allow later comparison with real ac-
quired values.
Animal experiments
Experimental procedures were performed in castrated-
male Large-White pigs. The study protocol was approvedby the Institutional Animal Research Committee and con-
ducted in accordance with recommendations of the Guide
for the Care and Use of Laboratory Animals.
Pigs were sedated by intramuscular injection of ketamine
(20 mg/kg), xylazine (2 mg/kg), and midazolam (0.5 mg/kg).
A marginal vein in the ear was cannulated for peripheral
intravenous access. Sedation was maintained by a continu-
ous intravenous infusion of ketamine (2 mg/kg/h), xylazine
(0.2 mg/kg/h) and midazolam (0.2 mg/kg/h).
The first in-vivo experiment was designed to evaluate
the R1 and R2* variations at different contrast concen-
trations during first-pass perfusion, in order to establish
the relationship between the two relaxation rates in-
vivo. In a second in-vivo experiment, 11 pigs with differ-
ent degrees of myocardial perfusion were examined
simultaneously by the dual-bolus and dual-saturation
methods to allow comparison of cardiac perfusion esti-
mates by the two approaches. For hypoperfusion, 6 pigs
underwent a closed-chest transmural myocardial infarc-
tion (45 minutes ischemia in the left anterior des-
cending coronary artery followed by reperfusion); the
procedure was performed with a dedicated percutan-
eous catheter inserted via the femoral artery [18,19].
Index CMR was performed 45 days post-infarction. For
regional hyperemia, 4 pigs were subjected to intracor-
onary infusion with sodium nitroprusiate (4 mg/kg) or
papaverine (0.5 mg/kg) during image acquisition inside
the MRI scanner. Normoperfusion was assessed in 1
healthy animal undergoing CMR.
In-vivo image acquisition
Evaluation of R1 and R2* changes at different contrast
concentrations during first-pass perfusion
To define the relation between R1 and R2* values and
contrast concentration in-vivo, different TS and TE were
acquired during first pass of the contrast agent. To esti-
mate R1 values every second, 6 saturation times were
acquired over the range from 3.2-328.2 ms, with inter-
vening gaps of 64.8 ms. The saturation times were ac-
quired by sharing the same saturation pulse between 6
slice locations in transverse orientation along the de-
scending aorta. The slices were acquired in ascending
order to ensure that a saturated blood signal due to RF
excitation pulses in one slice did not influence the signal
acquired from the other slices. To estimate R2* values
for every TS, four TE were acquired over the range from
0.8-3.8 ms with intervening gaps of 1.0 ms. The same
experiment was performed dynamically every second
over one minute, during which 0.1 mmol/kg of Gd-
DTPA Magnevist (Schering AG, Berlin, Germany) was
injected at a rate of 3 ml/s, followed by a 20 ml saline
flush.
For these experiments, R2* values were obtained by fit-
ting the signal at different TE to a mono-exponential
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at different TS, and the mean was taken as the final result.
R1 values were obtained by fitting the signal from different
TS at the shortest TE to a regular saturation recovery
model. After estimation of R2* and R1 for each dynamic
acquisition, the values of the two quantities were fitted to
a quadratic relation, as previously proposed [20].
Comparison between dual-bolus and dual-saturation
methods
To evaluate the two quantification strategies, dual-satur-
ation acquisition was combined with the dual-bolus in-
jection protocol. For dual-bolus injection, the injection
protocol was done using a single power MR injector
Spectris Solaris (Medrad, Warrendale, Pennsylvania)
using a previously described methodology by Ishida
et al. [11]. Two boluses of Gd-DTPA Magnevista
Figure 2 Sequence Details and AIF drawing for Low and High resolut
saturation time is interleaved acquired sharing the saturation pulse with th
dual saturation and dual bolus cases and an example of the signal-intensity
selection of the limits for diluted AIF.(Schering AG, Berlin, Germany) of equal volume and
different concentration (0.01 mmol/kg and 0.1 mmol/kg)
were injected at 3 ml/s, each followed by a 20-ml saline
flush. A waiting time of 25 s was established between
injections to ensure proper insulation of both curves
during image analysis.
Three high resolution images (voxel size 2.6×2.
6×10.0 mm3) and an additional interleaved low reso-
lution image (6.8×2.6×10.0 mm3) were acquired at
every R-R interval over 120 s. Interleaved low reso-
lution image was acquired between the saturation pulse
of the first high resolution image and image readout,
sharing the same saturation pulse between low and high
resolution images. To prevent any signal interaction be-
tween both images the planning was defined avoiding
crosses between slices. When the heart rate was above
120 bpm one high resolution slice was removed fromb
ion images. a) represents the sequence details showing the short
e first high resolution image. b) ROI example for AIF selection in the
curve at the high resolution. Dotted vertical lines represent the
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val. The image sequence consisted of spoiled TFE ac-
quisition with a saturation time of 100 ms for high
resolution images and 20 ms for low resolution images
(TR/TE/FA = 2.0 ms/0.9 ms/15°). Images were acquired
with reverse-linear profile ordering with a half scan fac-
tor of 75% and a SENSE factor of 2.6. All perfusion im-
ages were reconstructed to 2.0×2.0 mm2 in-plane
resolution. To obtain baseline T1 values, an additional
MOLLI (modified look-locker inversion recovery) T1
map was acquired with a 3–5 scheme [21] at the same
location before every perfusion scan.
The full image analysis to obtain flow information was
performed using custom software written in IDL8.1
(Exelis Visual Information Solutions, Boulder, Colorado).
Time-intensity curves were transformed into concen-
tration curves using the methodology described in the
Appendix for low and high resolution images and both
perfusion strategies. In dual-bolus analysis AIF was de-
fined by drawing a region of interest (ROI) in the left
ventricle cavity of high resolution images and manually
choosing the region of the time curve corresponding to
the first diluted contrast as the portion of the curve
between the first and second upslope shoulders of the
intensity curve (Figure 2b). The duration of the final
AIF was established as the time difference between both
temporal positions and the initial point was established
at the upslope shoulder of the full concentration injec-
tion (dashed lines in Figure 2b). After signal cropping
the diluted AIF was temporary registered to the full
contrast AIF to prevent shift with the muscle contrast
uptake by automatic method that find the maximum
correlation between both curves by temporal shifting of
diluted AIF. Finally, the diluted, cropped and registered
AIF was scaled according to the concentration differ-
ence. In dual-saturation analysis an ROI was drawn
on low resolution images with no scaling factor and
using the whole time curve in the deconvolution
process. Model-based deconvolution was used to esti-
mate flow, using an exponential model with 2 fitting
parameters:
h tð Þ ¼ F exp −kt½ ; ð5Þ
where F represents the magnitude of the function, dir-
ectly related to the blood flow, and k describes the decay
rate of h(t) due to contrast wash-out. No shift was
included in the model since AIF and cardiac muscle
contrast uptake were measured close enough, making
such correction unnecessary. Cardiac flow was assessed
by scaling the F value according to a muscle density of
1.05 g/ml and assuming a constant hematocrit of 0.35
following high permeability modelMBF ¼ F min
−1½ 
1−Hematocritð Þ  1:05 g=ml½  ð6Þ
After flow-map generation, a quantitative comparison
of the dual-bolus and dual-saturation methods was per-
formed by ROI analysis in the ischemic or hyperemic re-
gion and the contralateral wall for all acquired slices and
animals. The ROI was defined in the dual-bolus flow
maps and was copied to dual-saturation maps to extract
the final numerical data. Correlation and Bland-Altman
plot analysis were performed to compare flow measured
with the two approaches.
Results
Phantom experiments
Estimation of T1 values at different contrast concentrations
Table 1 shows the T1 and R1values of the different contrast
concentration tubes. These values were taken as the refer-
ence T1 values to assess signal behavior at different contrast
concentrations in subsequent phantom experiments. The
T1 values ranged from 3693 ms for the phantom without
contrast agent to 14 ms for a contrast concentration of
22 mM. This contrast concentration corresponds to the
upper limit observed in human experiments with a
0.1 mmol/kg contrast injection at a rate of 6 ml/s [22].
Evaluation of saturation times at different contrast
concentrations
The effect of the TS on signal intensity at different
contrast concentrations is shown in Figure 3. For a TS
of 10 ms, signal (S/SPD) increased linearly with contrast
concentration in the phantom, with a linear fitting
correlation coefficient of R2 = 0.986. In contrast, for a TS
Figure 3 Signal intensity for different Saturation times at several contrast concentration. Signal acquired for different contrast
concentrations at different saturation times (10, 20, 30, 40, 50, 60, 70, 80, 90 and 200 ms). The intensity values for each tube (S) were normalized
to the signal intensity of the image acquired without saturation pulse, which represents the fully recovered signal after saturation (SPD). The solid
black line represents the linear fitting of S/SPD for each tube and different R1 values. The solid gray line represents the conventional saturation
recovery signal model for a saturation time of 40 ms.
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contrast concentrations, with a value of S/SPD close to 1,
saturating the signal response.
Evaluation of profile ordering in estimates of final contrast
concentration
The effect of different readout strategies on the signal
intensity ratio at different contrast concentrations is rep-
resented in Figure 4. Signal intensity ratios were calcu-
lated by dividing the measured signal intensity of each
tube by the measured signal of the tube filled with pure
water, as described in the Appendix. Linear correlation
analysis between the measured Sc/Sb data (points in
Figure 4) and the signal model (solid lines) yielded
correlation coefficients of R2 = 0.999 and R2 = 0.998 for
reverse-linear and linear profile ordering, respectively.
The slopes between the model and the measured data
were 0.979 and 0.978 for reverse-linear and linear profile
ordering, respectively.In vivo data
Evaluation of R1 and R2* changes at different contrast
concentrations during first-pass perfusion
MR signal changes due to R1 and R2* effects during the
first-pass of bolus injection are shown in Figure 5. For
longer TE (Figure 5a) there is a drop in signal due to R2*
effects at very high contrast concentration. The effect of
R2* changes (ΔR2*) reached a maximum value of 39Hz
(Figure 5c). Figure 5b shows the effect on the MR signal ac-
quired with different TS during the same bolus injection.
For shorter TS the MR signal perfectly follows the contrast
bolus, whereas for longer TS the MR signal is fully relaxed,
reaching a plateau that limits the ability of the MR signal to
track the highest contrast concentrations. The R1 values
obtained after fitting the saturation recovery experiment for
each time domain point were normalized to those obtained
before contrast injection (ΔR1) (Figure 5d).
The relation between ΔR2* and ΔR1 (Figure 6) was fit-
ted to a quadratic relation [23], yielding a correlation
Figure 4 Read-out effects on signal intensity. The graph on the left represents the signal ratio between the signal of the phantoms at
different contrast concentrations and the signal of the tube without contrast for Reverse Linear (black squares) and Linear (gray circles) profile
ordering. Dotted lines represent the result of the same ratio derived from the signal model described in the appendix for both profile ordering
schemes. Solid lines represent the result of the signal model of Sc/Sb described in the Appendix for both readout strategies.
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quantities as follows:
ΔR2 ¼ 0:0332 ΔR21 þ 0:165 ΔR1 − 0:0003
The relation established in this equation between ΔR1
and ΔR2* effects was subsequently used for contrast
estimation in vivo.
Correlation between the dual-bolus and dual-saturation
methods
Representative MBF maps from both techniques are shown
in Figure 7 for post infarction left anterior descending cor-
onary artery (Figure 7a) and induced hyperemia of the right
coronary artery (Figure 7b). Flow measurements obtained
with the two methods (Figure 8) show a good linear rela-
tionship (R2 = 0.92). Bland-Altmann plot (Figure 9) shows a
small disparity of 0.1 ml/min/g between the two perfusion
measurements.
Discussion
In this study we present a validation analysis for myocar-
dial perfusion by dual-saturation acquisition including
in vitro and in vivo experiments for the most important
parameters affecting the quantification of absolute car-
diac perfusion. The in vitro results were included in a
comparison with the well-established dual-bolus tech-
nique in a pig model over a wide range of perfusionvalues. Our data show that a TS below 30 ms is suffi-
cient to avoid AIF saturation. Although a low TE is de-
sirable to avoid R2* effects on AIF estimation, we have
also described the relation between R1 and R2* during
bolus injection and included this in the conversion from
signal to contrast concentration. The dual-saturation
methodology was tested at flow values ranging from 0.12
to 3.92 ml/min/g, yielding a correlation coefficient with
dual-bolus acquisition close to 1 (R2 = 0.92).
This correlation is slightly higher than that previously
reported for analysis of the dual-bolus method with the
multiple saturation recovery times (m-SRT) technique
[24] (0.92 vs 0.82), probably due to the wider flow range
explored in the present study. Moreover, overestimation
of m-SRT quantitative perfusion has been reported at
low perfusion rates [24]. In our study, measurements
with the dual-bolus and dual-saturation methodologies
show good agreement at low flow rates, with a constant
level close to 0 (0.0048 ml/min/g). This discrepancy with
the previous report can be explained by the use of
higher contrast concentration in the present study.
Direct comparison of contrast concentration between
the two reports is difficult due to the use of different
contrast agents (Gd-DPTA here and Gd-BOPTA in
the previous report); however, here we use a fivefold
higher contrast volume for in-vivo experiments (0.1 vs
0.02 mmol/kg), while the r1 relaxivity of Gd-BOPTA is
just 1.31 times higher than that of Gd-DPTA [25].
a b
c d
Figure 5 In-vivo effect on the MR signal due to single bolus contrast injection. Example of the signal variation in the aortic blood for different contrast
concentrations and different echo times (a) and different saturation times (b), and the corresponding results of the R2* (c) and R1 (d) variations.
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saturation approach underestimates flow at high flow rates,
a result in agreement with previous findings [24]. This
effect can probably be explained by physiological changes
to the AIF in the dual-bolus approach at the high contrast
concentration and under stress conditions, where it can be
more difficult to maintain a constant and homogeneous
vasodilation. In contrast, these changes are not seen when
a single injection of contrast agent is used since AIF and
cardiac muscle information are acquired at the same time.
The Bland-Altman plot showed that the mean difference
between the two methods is 0.1 ml/min/g, which is the
minimum flow detected by both techniques and is thus
within the expected intrinsic error. The difference increases
at higher myocardial flows, probably due to a higher hetero-
geneity of flow distribution in the cardiac muscle.
In order to obtain reliable perfusion measurements it is
necessary to consider different potential factors that can
influence estimation of contrast concentration changes in
the blood pool (AIF) and cardiac muscle from the MRsignal. One factor is a high contrast concentration passing
through the ventricular cavity, which directly produces an
underestimate of AIF due to over-long TS selection and
R2* signal decay. A second factor is the readout effect of
the cardiac muscle MR signal in high resolution images
and its influence on the estimation of contrast concentra-
tion from the MR signal.
Accurate estimation of AIF first requires careful selec-
tion of the TS in order to avoid signal saturation at a too
high contrast concentration. The results presented in
Figure 3 show that in images acquired with TS values
below or equal to 30 ms there is no substantial satur-
ation effect on the MR signal for a maximum R1 of
71.69 Hz. Based on previously reported relaxivity values
of Magnevist at 3 T [23], this value corresponds to a
contrast concentration of 21.8 mM in aqueous solution
(Γ = 3.29Hz/mM at 3 T) and 19.97 mM in blood (Γ =
3.59Hz/mM at 3 T). This is within the range of previous
reported values for contrast concentration in the left
ventricle cavity of healthy volunteers receiving an
Figure 6 Correlation between R1 and R2* during same in-vivo bolus injection. Relation between the R2* variation and R1 variation
obtained from Figure 5 for all dynamics (black dots) and the quadratic fitting between both quantities.
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[16]. The figure also shows that a 200 ms TS allowed a
more detailed analysis of contrast concentrations below
4.24 mM (R1 = 13.95Hz) using the full signal recovery
range for this small contrast concentration window [6].
Unfortunately, at longer saturation times it is more diffi-
cult to acquire all slices in a single heartbeat, making it
necessary to use shorter saturation times.
The second source of error that can affect AIF estima-
tion at high contrast concentration is the potential for R2*
effects. This effect can be observed in Figure 5a. During
the same contrast injection different echoes are acquiredFigure 7 Representative Myocardial Blood Flow maps. Representative
(a) and selected hyperemia at right coronary artery (RCA) (b) estimated wi
and dual-saturation maps have equalized scales.with the corresponding R2* signal decay. With a contrast
dose of 0.1 mmol/kg injected at a rate of 3 ml/s the max-
imum ΔR2* value was 39Hz, which underestimated AIF
by 3.5% for the TE used in the present study (TE = 0.9 ms)
and by 2.2% for previously reported TE (TE = 0.58 ms)
[26]. This effect has been compensated for in the contrast
conversion procedure by using the estimated relation
between the R1 and R2* effects (Figure 4) in contrast
conversion curves. To be able to estimate this relation, R1
and R2* were estimated simultaneously during the same
contrast injection. Assuming a linear relation between
contrast concentration and R1 changes [23], a quadraticflow maps for left anterior descendant (LDA) coronary occlusion
th dual-bolus and dual-saturation strategies. In both cases dual-bolus
Figure 8 Correlation analysis between Dual Bolus and Dual Saturation MBF. Scatter plot and linear regression fitting (solid line) comparing
the quantitative results obtained with the dual-bolus and dual-saturation approaches (black dots).
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previously reported [15,22].
Readout effects are more pronounced in high resolution
images than in the AIF estimation due to the application
of higher turbo factors before reaching the center of theFigure 9 Bias plot between Dual Bolus and Dual Saturation MBF. Blan
dual-bolus and dual-saturation approaches.k-space. This series of RF pulses influences magnetization
and therefore the estimation of contrast concentration
within the cardiac muscle. The proposed signal model
demonstrates a good agreement with the acquired data,
yielding a correlation coefficient close to 1.d-Altman plot comparing the quantitative results obtained with the
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The main limitation of the present study is that the
dual-saturation method was compared to dual-bolus ac-
quisition as a gold standard. Comparison with micro-
spheres was not performed. However, the dual-bolus
method has consistently shown good agreement in
phantom analysis [27], with microspheres [10,28], and in
nuclear medicine in human studies [4].
Conclusions
The dual-saturation strategy for absolute quantification
of myocardial perfusion by 3T-CMR shows an almost
perfect correlation with the dual-bolus method across a
wide range of perfusion scenarios (form post-infarction
hypoperfusion to pharmacologically-induced hyperemic
status). The dual-saturation strategy is moreover easier
to implement in clinical protocols. Obtaining reliable
flow measurements with the dual-saturation strategy
requires careful selection of specific parameters. Chief
among these are the correct selection of TS to ensure
adequate evaluation of contrast uptake in the AIF (TS <
30 ms) and cardiac muscle (TS < 100 ms); the relation
between the contrast injection protocol and the R2*
effects on the AIF—always attempting to acquire images
with the shortest possible TE; and the readout scheme
for proper conversion of signal intensity changes into
real contrast uptake.
Appendix
For the contrast concentration used in clinical practice, a
linear relationship can be assumed between the changes
in contrast concentration and R1 variation in tissues. The
first step to assess contrast concentration changes is the
accurate evaluation of R1 changes (ΔR1) as the difference
between the tissue R1c after contrast injection and the
baseline R1b value. Accurate estimates of R1 variation
changes are therefore required for a proper estimation of
contrast concentration.
Conventional cardiac perfusion acquisitions are based
on a saturation recovery experiment followed by differ-
ent readout strategies normally based on acquisition
techniques for single-shot spoiled turbo field echo (TFE)
or hybrid spoiled TFE echo planar imaging (TFE-EPI).
TFE acquisition is normally desired since shorter echo
times are achievable, thus making this approach less sensi-
tive to R2* [29]. The signal model described in this report
can be applied to both TFE and TFE-EPI.
To obtain reliable R1 changes it is necessary to have a
detailed understanding of the progress of magnetization
between the saturation pulse and the center of the k-
space (k0), where the contrast of the image is generated.
In saturation recovery experiment (Figure 2) the MR
signal recovers after the saturation pulse with the corre-
sponding T1 value according to equation [A1]ST0 ¼ S0e−R2bTE 1−e−R1bT0
 
; ðA1Þ
where T0 is the time between the saturation pulse
and the starting point of the image readout; R1b and
S0 are R1 and the fully recovered signal intensity of
the tissue; TE is the sequence echo time; and R2b* rep-
resents the transverse relaxation rate. After T0 the im-
aging readout sequence starts with different excitation
pulses that affect the spin magnetization before reach-
ing the center of the k-space, where the image con-
trast is defined. These signal changes can be expressed
as:







where TS is the defined saturation time in the acquisi-
tion sequence, and R1b and S

0 are the modified R1 and
steady-state magnetization of a spoiled gradient echo ac-









TR−T1 ln cos αð Þð Þ ; ðA3Þ
where TR is the time between two consecutive excita-
tion pulses and α is the TFE excitation angle. From
equation [A2] and [A3] it can be shown that the signal
will be more affected when more excitation pulses are
applied between the saturation pulse and the acquisition
of image k0. This difference can change with image
resolution, profile order, half scan and parallel imaging
acquisition factor.
The change in contrast concentration over time can
be obtained from the ratio of signal intensity in the
baseline situation before contrast injection (Sb) to the
signal intensity after contrast arrival (Sc). By including
the signal model described in Eq [A2] in the ratio it
can be demonstrated that the signal relation follows
the signal model described by
Sc
Sb
C1 ¼ e−TEΔR2 − − 1−e−R1cT0




C1 ¼ −ð− 1−e−R1bT0
 Þe−R1b TS−T0ð Þ and 1
T1c
¼ R1c ¼ R1b þ ΔR1
Equation A4 states that with knowledge of the baseline
T1 obtained by MOLLI sequence [21], the concentration of
the contrast agent can be obtained at any time domain
point by using the baseline signal as a normalization factor.
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